January 21, 2026
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has been named a Clarivate Top 100 Global Innovator for 2026 for the 13th consecutive year. Philips is the highest-ranking medical technology company included in the report, underscoring its continued leadership in healthcare innovation.
“Building on more than 130 years of innovation, Philips is driven by a clear purpose to deliver better care for more people,” said Roy Jakobs, CEO of Royal Philips. “Our innovations help healthcare professionals deliver high-quality patient care and empower people to manage their health and well-being at home. Being recognized as a Clarivate Top 100 Global Innovator reflects our commitment to people-centered, scalable innovation that improves outcomes and expands access to care.”
Philips'recognition reflects its long-term commitment to innovation, supported by more than EUR 1.7 billion in annual R&D investment – approximately 9% of sales and among the highest levels in the industry. Across professional healthcare and consumer health, Philips is applying AI-enabled technologies, advanced imaging, and connected platforms to support more precise diagnosis, simplify workflows, and empower people to proactively manage their health and well-being. Examples of Philips' latest innovations include:
The Clarivate Top 100 Global Innovators report uses a complete comparative analysis of global invention data to assess the strength of every patented idea, using measures tied directly to their innovative power. The full Clarivate Top 100 Global Innovators 2026 report can be found here.
[1] Helium-free operations. 7 liters of helium is permanently enclosed in the cryogenic circuit.
For further information, please contact:
Michael Fuchs
Philips Global External Relations
Tel.: +31 614869261
E-mail: Michael.Fuchs@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips'patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
随机文章
热门文章

V1.0重磅发布!四维天穹绘构低空天路
Merck Appoints David Weinreich as New Global Head of R&D and Chief Medical Officer for Healthcar
“兴火·燎原”总冠军诞生,云宏信息《金融高算力轻量云平台》登顶
泳池过滤器怎么选?揭开Waternics水武仕珍珠岩过滤器的“硬核密码”!
Graco推出QUANTM电动双隔膜泵系列的改进产品
2025上海CMEF:鱼跃以“AI+医疗”开启健康管理新纪元
再获殊荣!itc分布式综合管理平台荣获2024年度“分布式处理十大品牌”
北京爱育华医院耳鼻喉头颈外科高品质服务升级
交个朋友严选背后:为何是蛰伏三年的酃酃酒